Status:
COMPLETED
Interleukin 20 and Periodontal Tisuue Destruction
Lead Sponsor:
Recep Tayyip Erdogan University
Conditions:
Periodontitis
Eligibility:
All Genders
20-65 years
Brief Summary
Periodontitis is an inflammatory disease that causes destruction of periodontal tissues. IL-20, on the other hand, is known as a potent angiogenic, chemotactic, and pro-inflammatory cytokine associate...
Eligibility Criteria
Inclusion
- The following criteria were required for inclusion: being systemically healthy, not smoking, not using antibiotics or systemic corticosteroids within the previous three months, not being pregnant or nursing, not having a chronic inflammatory disease, not receiving periodontal therapy within the previous six months, and possessing at least 20 teeth
Exclusion
- smoking, using antibiotics or systemic corticosteroids within the previous three months, pregnant, receiving periodontal therapy within the previous six months
Key Trial Info
Start Date :
June 6 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 6 2023
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06091800
Start Date
June 6 2022
End Date
June 6 2023
Last Update
October 19 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Recep Tayyip Erdogan University
Rize, Turkey (Türkiye)